RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
Thromb Haemost 2000; 83(05): 789-790
DOI: 10.1055/s-0037-1613913
DOI: 10.1055/s-0037-1613913
Letters to the Editor
New Recombinant Standard for FVIII Concentrate Gives Same Results as Previous Plasma Derived Standards on a Range of FVIII Products
Weitere Informationen
Publikationsverlauf
Received
25. Oktober 1999
Accepted after resubmission
18. Januar 2000
Publikationsdatum:
08. Dezember 2017 (online)
-
References
- 1 Lee C. Recombinant clotting factors in the treatment of hemophilia. Thromb Haemost 1999; 82 (State of the Art): 516-24.
- 2 Barrowcliffe TW. Factor VIII and Factor IX Sub-committee. Recommendations for the assay of high-purity factor VIII concentrates. Thromb Haemost 1993; 70 (05) 876-7.
- 3 Barrowcliffe TW, Raut S, Hubbard AR. Discrepancies in potency assignment of recombinant FVIII concentrates. Haemophilia 1998; 04: 634-40.
- 4 Barrowcliffe TW. Standardization and assay. Semin Thromb Hemost 1993; 19 (01) 73-9.
- 5 Raut S, Heath A, Barrowcliffe TW. 6th International Standard for FVIII concentrate. NIBSC unpublished report.
- 6 Mikaelsson M, Oswaldsson U, Sandberg H. Influence of phospholipids on the assessment of factor VIII activity. Haemophilia 1998; 04: 646-50.